168 related articles for article (PubMed ID: 36947331)
1. Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial Fibrillation.
Alberts M; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
Adv Ther; 2023 May; 40(5):2339-2354. PubMed ID: 36947331
[TBL] [Abstract][Full Text] [Related]
2. Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapy.
Alberts MJ; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
Curr Med Res Opin; 2023 Sep; 39(9):1279-1286. PubMed ID: 37589313
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation.
Mehta HB; An H; Ardeshirrouhanifard S; Raji MA; Alexander GC; Segal JB
Circ Cardiovasc Qual Outcomes; 2022 Dec; 15(12):e008951. PubMed ID: 36453260
[TBL] [Abstract][Full Text] [Related]
4. Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation.
Álvaro Thomsen T; Mesa Guadalupe J; Huerta C; de Burgos A; Cea Soriano L
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5733. PubMed ID: 38011912
[TBL] [Abstract][Full Text] [Related]
5. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.
Shiozawa M; Koga M; Inoue H; Yamashita T; Yasaka M; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Nakahara J; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T; Toyoda K
Int J Stroke; 2023 Oct; 18(8):986-995. PubMed ID: 37154598
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity.
Dhamane AD; Ferri M; Keshishian A; Russ C; Atreja N; Gutierrez C; Emir B; Yuce H; Di Fusco M
Adv Ther; 2023 Mar; 40(3):887-902. PubMed ID: 36527598
[TBL] [Abstract][Full Text] [Related]
8. Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation.
Yang Y; Kim M; Kim J; Cho MS; Lee S; Song JM; Kim DH
J Am Heart Assoc; 2024 Feb; 13(3):e032272. PubMed ID: 38293966
[TBL] [Abstract][Full Text] [Related]
9. Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population.
Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Rosenblatt L; Liu X; Hede S; Nadkarni A; Shank T
J Manag Care Spec Pharm; 2018 Nov; 24(11):1116-1127. PubMed ID: 30212268
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study.
Alberts M; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
Int J Clin Pharm; 2023 Aug; 45(4):952-961. PubMed ID: 37204616
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
Lawal OD; Aronow HD; Shobayo F; Hume AL; Taveira TH; Matson KL; Zhang Y; Wen X
Circulation; 2023 Mar; 147(10):782-794. PubMed ID: 36762560
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data.
Enomoto A; Mano Y; Kawano Y; Nishikawa T; Aoyama T; Sasaki Y; Nagata M; Takahashi H
Biol Pharm Bull; 2021; 44(9):1294-1302. PubMed ID: 34471057
[TBL] [Abstract][Full Text] [Related]
13. Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease.
Douros A; Cui Y; Platt RW; Filion KB; Sebastiani G; Renoux C
Br J Clin Pharmacol; 2022 Mar; 88(3):994-1009. PubMed ID: 34409636
[TBL] [Abstract][Full Text] [Related]
14. Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism.
Chan YH; Wu LS; See LC; Liu JR; Chang SH; Chao TF; Yeh YH; Kuo CT; Lee HF; Lip GYH
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32009154
[TBL] [Abstract][Full Text] [Related]
15. Effects of a Pharmacist-Led Educational Interventional Program on Electronic Monitoring-assessed Adherence to Direct Oral Anticoagulants: A Randomized, Controlled Trial in Patients with Nonvalvular Atrial Fibrillation.
Shiga T; Kimura T; Fukushima N; Yoshiyama Y; Iwade K; Mori F; Ajiro Y; Haruta S; Yamada Y; Sawada E; Hagiwara N;
Clin Ther; 2022 Nov; 44(11):1494-1505. PubMed ID: 36244853
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study.
Alberts M; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Bookhart B; Kharat A
Adv Ther; 2023 Apr; 40(4):1750-1764. PubMed ID: 36823479
[TBL] [Abstract][Full Text] [Related]
17. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
[TBL] [Abstract][Full Text] [Related]
18. Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry.
Yamashiro K; Tanaka R; Miyazaki S; Miyauchi K; Hayashi H; Nishizaki Y; Nojiri S; Suwa S; Sumiyosi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106871. PubMed ID: 36356431
[TBL] [Abstract][Full Text] [Related]
19. Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands.
Chen Q; Toorop MMA; Tops LF; Lijfering WM; Cannegieter SC
JAMA Netw Open; 2023 Apr; 6(4):e239973. PubMed ID: 37097630
[TBL] [Abstract][Full Text] [Related]
20. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
